Irisin test for early detection of diabetic kidney disease
Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial is testing whether a hormone called irisin in the blood can help detect diabetic kidney disease early and show how it progresses. If you have type 2 diabetes, participating may help improve how kidney problems are found and monitored.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have type 2 diabetes.
- You must not have kidney disease from causes other than diabetes.
- You must not have acute illness, infection, obesity, high blood pressure, or type 1 diabetes.
- You must not have cancer, other hormone-related conditions, or be taking corticosteroids.
- You must not be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at simple blood tests to see if certain markers of inflammation and platelet levels are different in people with diabetic kidney disease compared to healthy people. The results might help doctors find kidney problems earlier in people with type 2 diabetes.
This study helps people with type 2 diabetes get the right kidney tests to catch kidney problems early. Your doctor will check your kidney health through a simple blood and urine test.
This study looks at whether a protein in your blood called irisin is linked to nerve damage caused by diabetes. It may help doctors find better ways to test for and manage diabetic nerve pain.
This study looks at whether a natural protein called irisin in your body affects erectile function in men with type 2 diabetes and obesity. By comparing blood and tissue levels, the researchers hope to find new ways to improve erectile function in men who haven't responded to current treatments.
This study looks for early warning signs in blood or other samples (using a special lab approach) to detect kidney problems sooner in people with diabetes. It may help patients and clinicians identify kidney risk earlier and follow changes over many years.
This study is testing a new way to find early signs of kidney damage in people with diabetes. The goal is to catch kidney disease (diabetic nephropathy) sooner, so it can be managed more effectively.
Hear when a new Diabetic Nephropathies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.